Summary: Probo Medical has appointed Michael Asmer as chairman of the board and Greg Kopulos as CEO. The leadership changes come as Probo continues to grow and integrate recent acquisitions, positioning itself as a global leader in diagnostic imaging solutions.
Key Takeaways:
- Michael Asmer transitions from CEO to chairman of the board, while Greg Kopulos, formerly of Chartis and GE Healthcare, takes on the CEO role.
- Probo Medical, backed by Avista Healthcare Partners, aims to expand its diagnostic imaging solutions and support its customers through growth and integration.
Probo Medical, a global diagnostic imaging solutions provider, has announced the appointment of Michael Asmer as chairman of the board and Greg Kopulos as chief executive officer.
Michael Asmer’s New Role as Chairman
Asmer was formerly CEO of Probo and, prior to that, was the founder and CEO of MedCorp, which was acquired by Probo in 2018. He also held various leadership roles at Physician Sales and Service (PSS) before its acquisition by McKesson, as well as at Henry Schein. Asmer earned his Bachelor’s degree from the University of South Carolina.
“I am tremendously proud of what our team has accomplished over the last five years at Probo and am also excited for what lies ahead,” said Asmer. “With the integration of recent acquisitions, Probo enters a new phase of growth where we can support our customers with a comprehensive offering of diagnostic imaging solutions.”
Greg Kopulos Appointed as CEO
Kopulos joined Probo in 2024 from Chartis, a healthcare consulting firm where he was president of their Clinical Quality Solutions business. Before that, he spent 20 years at GE Healthcare, where he served in roles such as chief operating officer of global service, COO of US and Canada, and senior vice president of strategy. Kopulos earned his Master’s of Business Administration from Marquette University and his Bachelor’s degree from the University of Wisconsin-Whitewater.
“Probo is well on its way to becoming a global leader in diagnostic imaging solutions. I am humbled and excited to build on the great work of Michael and the entire Probo team,” said Kopulos. “With the continued investment in and integration of our prior acquisitions, Probo has never been better positioned to help our customers deliver quality care to their patients while providing needed cost savings.”
Probo Medical is backed by Avista Healthcare Partners, a leading private equity firm focused exclusively on healthcare, with over $8 billion invested in more than 45 growth-oriented healthcare businesses globally.
